Canada Pension Plan Investment Board Buys Shares of 662,989 CME Group Inc. $CME

Canada Pension Plan Investment Board purchased a new position in shares of CME Group Inc. (NASDAQ:CME) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 662,989 shares of the financial services provider’s stock, valued at approximately $146,408,000. Canada Pension Plan Investment Board owned approximately 0.18% of CME Group at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in CME. Whipplewood Advisors LLC raised its holdings in CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 83 shares in the last quarter. Elkhorn Partners Limited Partnership bought a new position in CME Group during the 4th quarter valued at $27,000. Hilton Head Capital Partners LLC bought a new position in CME Group during the 4th quarter valued at $28,000. Mowery & Schoenfeld Wealth Management LLC acquired a new position in shares of CME Group during the 2nd quarter valued at $28,000. Finally, Legacy Wealth Managment LLC ID increased its position in shares of CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 71 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at CME Group

In other news, Director William R. Shepard acquired 325 shares of CME Group stock in a transaction on Thursday, June 25th. The stock was bought at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the purchase, the director owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.30% of the company’s stock.

CME Group Price Performance

NASDAQ CME opened at $280.98 on Thursday. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The business’s fifty day moving average is $252.32 and its two-hundred day moving average is $279.24. The stock has a market capitalization of $101.03 billion, a P/E ratio of 23.83, a P/E/G ratio of 3.30 and a beta of 0.23. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company’s quarterly revenue was up .8% on a year-over-year basis. During the same period in the previous year, the firm posted $2.96 EPS. On average, research analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be paid a $1.30 dividend. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

Analyst Ratings Changes

CME has been the topic of a number of research reports. Weiss Ratings downgraded CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. UBS Group decreased their target price on CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a research note on Monday, July 6th. Piper Sandler lowered their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a report on Wednesday, July 15th. Morgan Stanley boosted their price target on shares of CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a research report on Thursday, July 23rd. Finally, Keefe, Bruyette & Woods raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price target for the company in a report on Thursday, June 18th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, CME Group has a consensus rating of “Hold” and a consensus price target of $288.56.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.